{"id":13796,"date":"2021-03-25T14:00:01","date_gmt":"2021-03-25T14:00:01","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/"},"modified":"2026-02-11T09:47:37","modified_gmt":"2026-02-11T09:47:37","slug":"les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/","title":{"rendered":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&rsquo;unissent pour former Sygnature Discovery."},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Ces derni\u00e8res ann\u00e9es, Sygnature Discovery a acquis deux des CRO les plus respect\u00e9es du Royaume-Uni : RenaSci et XenoGesis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00c0 compter de ce mois-ci, les \u00e9quipes et les services fournis par ces deux soci\u00e9t\u00e9s seront pleinement int\u00e9gr\u00e9s sous la marque Sygnature Discovery, cr\u00e9ant ainsi l&rsquo;une des<\/span> <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/integrated-drug-discovery\/\"><span style=\"font-weight: 400;\">plateformes de d\u00e9couverte de m\u00e9dicaments int\u00e9gr\u00e9es<\/span><\/a> les plus compl\u00e8tes <span style=\"font-weight: 400;\">du march\u00e9 actuel.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00c0 l&rsquo;avenir, les marques RenaSci et XenoGesis ne seront plus utilis\u00e9es, mais leur expertise, leur r\u00e9putation d&rsquo;excellence scientifique et leurs succ\u00e8s retentissants dans l&rsquo;industrie des sciences de la vie perdureront sous la marque Sygnature.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fond\u00e9e en 2001, RenaSci propose une offre int\u00e9gr\u00e9e de<\/span> services de conseil <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/in-vivo-pharmacology\/\"><span style=\"font-weight: 400;\">en pharmacologie<\/span> <i><span style=\"font-weight: 400;\">in vivo<\/span><\/i><\/a> <span style=\"font-weight: 400;\">et de services exp\u00e9rimentaux, aidant ainsi des clients de tous les secteurs de l&rsquo;industrie pharmaceutique et biotechnologique \u00e0 optimiser leur productivit\u00e9 en recherche et \u00e0 rationaliser le d\u00e9veloppement de leurs m\u00e9dicaments. Cette acquisition en 2018 a constitu\u00e9 une \u00e9tape majeure dans notre mission d&rsquo;accompagner nos clients<\/span> tout au long <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/\"><span style=\"font-weight: 400;\">du processus de d\u00e9couverte de m\u00e9dicaments<\/span><\/a> <span style=\"font-weight: 400;\">, de la validation <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/computer-aided-drug-design\/target-analysis\/\">des cibles<\/a> jusqu&rsquo;aux solutions pr\u00e9cliniques.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fond\u00e9e en 2011, XenoGesis est devenue la plus importante CRO ind\u00e9pendante du Royaume-Uni, sp\u00e9cialis\u00e9e dans les \u00e9tudes pr\u00e9cliniques DMPK, la bioanalyse quantitative,<\/span> la pharmacologie <i><span style=\"font-weight: 400;\">in vitro<\/span><\/i> <span style=\"font-weight: 400;\">et l&rsquo;interpr\u00e9tation d&rsquo;\u00e9tudes cliniques. Cette acquisition, r\u00e9alis\u00e9e en 2020, a doubl\u00e9 la taille de notre<\/span> <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/dmpk-and-physical-sciences\/\"><span style=\"font-weight: 400;\">d\u00e9partement DMPK<\/span><\/a> <span style=\"font-weight: 400;\">, nous permettant ainsi de r\u00e9pondre \u00e0 une demande croissante et d&rsquo;\u00e9tendre notre pr\u00e9sence dans le domaine pr\u00e9clinique gr\u00e2ce \u00e0 de nouvelles expertises et comp\u00e9tences.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">XenoGesis et RenaSci \u00e9taient toutes deux bas\u00e9es aux c\u00f4t\u00e9s de Sygnature ici \u00e0 BioCity, Nottingham, ce qui correspondait \u00e9galement \u00e0 notre philosophie fondamentale consistant \u00e0 avoir des \u00e9quipes multidisciplinaires de chercheurs experts travaillant et r\u00e9solvant des probl\u00e8mes ensemble, facilitant ainsi la d\u00e9couverte de m\u00e9dicaments et cr\u00e9ant des solutions innovantes pour nos partenaires.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00ab Nous avons toujours \u00e9t\u00e9 anim\u00e9s par la volont\u00e9 non seulement de cro\u00eetre, mais aussi d&rsquo;am\u00e9liorer la d\u00e9couverte de m\u00e9dicaments \u00bb, a d\u00e9clar\u00e9 le Dr Simon Hirst, PDG de Sygnature. \u00ab Chaque \u00e9tape franchie dans le processus de d\u00e9couverte de m\u00e9dicaments nous permet d&rsquo;affiner nos m\u00e9thodes de travail. Gr\u00e2ce \u00e0 notre int\u00e9gration compl\u00e8te, avec nos \u00e9quipes regroup\u00e9es sur un m\u00eame site et travaillant de concert, nous n&rsquo;ajoutons pas simplement un nouveau service, nous am\u00e9liorons l&rsquo;ensemble de nos services. Nous \u00e9largissons ainsi le vivier de comp\u00e9tences et d&rsquo;expertises disponibles pour relever tous les d\u00e9fis. C&rsquo;est donc une p\u00e9riode particuli\u00e8rement stimulante, et nous sommes ravis d&rsquo;accueillir XenoGesis et RenaSci au sein de la famille Sygnature. \u00bb <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Alors que plus de 300 chercheurs de Sygnature sont bas\u00e9s \u00e0 notre si\u00e8ge social de Nottingham, Sygnature recrute actuellement massivement pour son deuxi\u00e8me site int\u00e9gr\u00e9 de d\u00e9couverte de m\u00e9dicaments \u00e0 Alderley Park, dans le Cheshire, o\u00f9 nous avons r\u00e9cemment commenc\u00e9 \u00e0 emm\u00e9nager dans de nouveaux laboratoires ultramodernes con\u00e7us pour toutes nos disciplines principales.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[992,816],"tags":[1019,1017,1026,1011,1024,824,1018,1025,1016,1010,1014,1009,1020,1029,1015,1021,1013,1012,1028,1030,1027,1023,1022,1031],"class_list":["post-13796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dmpk","category-pharmacologie-in-vivo","tag-acquisitions-cro","tag-avantage-de-la-colocalisation","tag-bioanalyse-quantitative","tag-chercheurs-scientifiques","tag-collaboration-multidisciplinaire","tag-decouverte-de-la-signature","tag-disciplines-fondamentales","tag-dmpk-preclinique","tag-equipes-colocalisees","tag-excellence-scientifique","tag-extension-du-parc-alderley","tag-industrie-des-sciences-de-la-vie","tag-integration-des-expertises","tag-laboratoires-de-pointe","tag-pdg-dr-simon-hirst","tag-pharmacologie-in-vitro","tag-pharmacologie-in-vivo","tag-plateforme-de-decouverte-de-medicaments","tag-productivite-de-la-recherche","tag-rationaliser-le-developpement-des-medicaments","tag-renasci","tag-services-integres","tag-solutions-innovantes","tag-xenogesis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&#039;unissent pour former Sygnature Discovery. - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&#039;unissent pour former Sygnature Discovery. - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-25T14:00:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:47:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"971\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&rsquo;unissent pour former Sygnature Discovery.\",\"datePublished\":\"2021-03-25T14:00:01+00:00\",\"dateModified\":\"2026-02-11T09:47:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\"},\"wordCount\":546,\"publisher\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg\",\"keywords\":[\"Acquisitions CRO\",\"Avantage de la colocalisation\",\"Bioanalyse quantitative\",\"chercheurs scientifiques\",\"Collaboration multidisciplinaire\",\"D\u00e9couverte de la signature\",\"Disciplines fondamentales\",\"DMPK pr\u00e9clinique\",\"\u00c9quipes colocalis\u00e9es\",\"Excellence scientifique\",\"Extension du parc Alderley\",\"industrie des sciences de la vie\",\"Int\u00e9gration des expertises\",\"Laboratoires de pointe\",\"PDG Dr. Simon Hirst\",\"Pharmacologie in vitro\",\"Pharmacologie in vivo\",\"Plateforme de d\u00e9couverte de m\u00e9dicaments\",\"Productivit\u00e9 de la recherche\",\"Rationaliser le d\u00e9veloppement des m\u00e9dicaments\",\"RenaSci\",\"Services int\u00e9gr\u00e9s\",\"Solutions innovantes\",\"X\u00e9nog\u00e9sis\"],\"articleSection\":[\"DMPK\",\"pharmacologie in vivo\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\",\"name\":\"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s'unissent pour former Sygnature Discovery. - Sygnature\",\"isPartOf\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg\",\"datePublished\":\"2021-03-25T14:00:01+00:00\",\"dateModified\":\"2026-02-11T09:47:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg\",\"width\":1800,\"height\":971},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&#8217;unissent pour former Sygnature Discovery.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\/\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s'unissent pour former Sygnature Discovery. - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/","og_locale":"fr_CA","og_type":"article","og_title":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s'unissent pour former Sygnature Discovery. - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/","og_site_name":"Sygnature","article_published_time":"2021-03-25T14:00:01+00:00","article_modified_time":"2026-02-11T09:47:37+00:00","og_image":[{"width":1800,"height":971,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg","type":"image\/jpeg"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&rsquo;unissent pour former Sygnature Discovery.","datePublished":"2021-03-25T14:00:01+00:00","dateModified":"2026-02-11T09:47:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/"},"wordCount":546,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg","keywords":["Acquisitions CRO","Avantage de la colocalisation","Bioanalyse quantitative","chercheurs scientifiques","Collaboration multidisciplinaire","D\u00e9couverte de la signature","Disciplines fondamentales","DMPK pr\u00e9clinique","\u00c9quipes colocalis\u00e9es","Excellence scientifique","Extension du parc Alderley","industrie des sciences de la vie","Int\u00e9gration des expertises","Laboratoires de pointe","PDG Dr. Simon Hirst","Pharmacologie in vitro","Pharmacologie in vivo","Plateforme de d\u00e9couverte de m\u00e9dicaments","Productivit\u00e9 de la recherche","Rationaliser le d\u00e9veloppement des m\u00e9dicaments","RenaSci","Services int\u00e9gr\u00e9s","Solutions innovantes","X\u00e9nog\u00e9sis"],"articleSection":["DMPK","pharmacologie in vivo"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/","name":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s'unissent pour former Sygnature Discovery. - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg","datePublished":"2021-03-25T14:00:01+00:00","dateModified":"2026-02-11T09:47:37+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/PRP1214-web.jpg","width":1800,"height":971},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/les-principales-cro-britanniques-specialisees-dans-la-decouverte-de-medicaments-sunissent-pour-former-sygnature-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Les principales CRO britanniques sp\u00e9cialis\u00e9es dans la d\u00e9couverte de m\u00e9dicaments s&#8217;unissent pour former Sygnature Discovery."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13796"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13796\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13800"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}